These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18817579)

  • 21. Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.
    Morgan RL; Kelley L; Guyatt GH; Johnson A; Lavis JN
    J Clin Epidemiol; 2018 Feb; 94():143-150. PubMed ID: 28988959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of costs.
    Riewpaiboon A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OMERACT: economic evaluations and health policy.
    Ruff B
    J Rheumatol; 2001 Mar; 28(3):666-9. PubMed ID: 11296979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision making.
    Jan S
    Appl Health Econ Health Policy; 2003; 2(1):17-24. PubMed ID: 14619270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of state and non-state actors in the policy process: the contribution of policy networks to the scale-up of antiretroviral therapy in Thailand.
    Tantivess S; Walt G
    Health Policy Plan; 2008 Sep; 23(5):328-38. PubMed ID: 18658197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for health technology assessment in Thailand (second edition)--the development process.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S4-9. PubMed ID: 24964693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand.
    Chaikledkaew U; Lertpitakpong C; Teerawattananon Y; Thavorncharoensap M; Tangcharoensathien V
    Value Health; 2009; 12 Suppl 3():S31-5. PubMed ID: 20586978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intelligent policy making? Key actors' perspectives on the development and implementation of an early years' initiative in Scotland's public health arena.
    Deas L; Mattu L; Gnich W
    Soc Sci Med; 2013 Nov; 96():1-8. PubMed ID: 24034945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
    Lee KS; Brouwer WB; Lee SI; Koo HW
    Pharmacoeconomics; 2005; 23(7):709-21. PubMed ID: 15987227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public healthcare resource allocation and the Rule of Rescue.
    Cookson R; McCabe C; Tsuchiya A
    J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How commercial actors used different types of power to influence policy on restricting food marketing: a qualitative study with policy actors in Thailand.
    Phulkerd S; Collin J; Ngqangashe Y; Thow AM; Schram A; Huckel Schneider C; Friel S
    BMJ Open; 2022 Oct; 12(10):e063539. PubMed ID: 36229148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.
    Hopman HA; Crowcroft NS; Cesuroglu T; Langley JM
    Vaccine; 2020 Mar; 38(11):2512-2518. PubMed ID: 32057578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand.
    Teerawattananon Y; Tritasavit N; Suchonwanich N; Kingkaew P
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):397-404. PubMed ID: 25444298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation.
    Iglesias CP; Drummond MF; Rovira J;
    Int J Technol Assess Health Care; 2005; 21(1):1-14. PubMed ID: 15736509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard cost lists for health economic evaluation in Thailand.
    Riewpaiboon A
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S127-34. PubMed ID: 24964710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the role of "the hidden curriculum" in resource allocation--the case of the UK NHS.
    Wirtz V; Cribb A; Barber N
    Health Care Anal; 2003 Dec; 11(4):295-300. PubMed ID: 14769011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical policy analysis of an emerging agenda for home care in one Canadian province.
    Duncan S; Reutter L
    Health Soc Care Community; 2006 May; 14(3):242-53. PubMed ID: 16650121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.